Gemalto delivers micro-banking technology in Bangladesh
June 3, 2013
Gemalto (Euronext NL0000400653 GTO), the world leader in digital security, is providing its smart card based solution to Dipon Consultancy Services Limited (DCSL) for their financial inclusion project in Bangladesh. DCSL is implementing this project in collaboration with Prime Bank Limited (PBL). The program named Prime Cash which represents over 76% of the country’s 150 million-population1 aims to provide secure access to banking services for people with limited or no access to banking services in both rural and urban areas in Bangladesh.
...
Rolman Group to Move into its 33,000 sqm State-of-the-art Headquarters Facility in JAFZA in Q3 2013
June 2, 2013
The Rolman Group, a Dubai-based company, which is one of the largest and most established distributors of bearings and related technical application-specific services in the Middle East and Africa, announces its move into its new larger state-of-the-art headquarters in the Jebel Ali Free Zone Authority (JAFZA) in Dubai. The lease agreement was signed in JAFZA by Dr. Abdulla Al Banna, Vice President of Commercial Sales and"...
Superiority of afatinib* over comparator chemotherapy for patients with EGFR mutation-positive advanced lung cancer is reinforced by second Phase III study
June 2, 2013
Data from Boehringer Ingelheim’s LUX-Lung 6 trial, presented at the official American Society of Clinical Oncology (ASCO) Annual Conference, demonstrate that patients treated with the novel, investigational compound afatinib* lived for almost one year before their tumour started to grow again, compared to less than half a year for those on standard chemotherapy (gemcitabine/cisplatin). Tumour assessment was based on independent review of the data showing progression-free survival (PFS) of 11.0 months for afatinib* and"...
Toshiba Launches Demodulator IC for China Digital Terrestrial and Digital Cable Broadcasts
June 1, 2013
Toshiba Corporation (TOKYO:6502) today announced that it has launched a demodulator IC for digital terrestrial broadcasts (GB20600-2006: DTMB) and digital cable broadcasts (GY/T 170-2001: DVB-C) in the Chinese market. Samples are available now with mass production scheduled to start this summer.
The new demodulator IC, TC90518FTG, uses Toshiba's original multipath1 cancelling technology and achieves industry-leading-class2"......
Syska Hennessy Group MENA Continues Growth and Expansion of Dubai Office
June 1, 2013
Syska Hennessy Group, Inc., a global consulting, engineering and commissioning firm, is growing to meet the increasing demands of their clients in the Middle East and North Africa (MENA) region. They are moving their Syska Hennessy Group MENA office into expanded space in Dubai’s Internet City, and increasing their engineering staff to support a growing demand in the Facilities Management Consulting, Commissioning (FMCx), Hospitality and Healthcare markets.
The"......
Oral Anti-Cancer Therapy Pomalidomide Celgene Receives Positive CHMP Opinion as Treatment for Patients with Relapsed and Refractory Multiple Myeloma
June 1, 2013
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that the European Medicines Agency’s (EMA): Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Pomalidomide Celgene in combination with dexamethasone for the treatment of relapsed and refractory multiple myeloma (rrMM) in patients who have received at least two prior therapies, including both lenalidomide and bortezomib, and have demonstrated disease progression while"...
Takeda Highlights Data from Clinical Trial Examining the Use of ADCETRIS® (Brentuximab Vedotin) in Pediatric Patients
June 1, 2013
2013 ASCO Annual Meeting Takeda Pharmaceutical Company Limited (TSE:4502) today announced interim data from a Phase 1/2, open-label, multicenter study with ADCETRIS® (brentuximab vedotin) in pediatric patients diagnosed with CD30-positive relapsed or refractory Hodgkin lymphoma (HL) or relapsed or refractory systemic anaplastic large cell lymphoma (sALCL). Data were presented from the Phase 1 portion of the study, which evaluated the safety, maximum"...
Quintiles Releases Perspectives on Early Phase Oncology and Hematology Biomarkers
June 1, 2013
In advance of the American Society of Clinical Oncology (ASCO) Annual Meeting, Quintiles today announced the release of its perspective on two areas of focus for clinical oncologists – the impact of patient selection in early-phase studies and the use of biomarkers in the treatment of hematologic malignancies. The first of these reports, ...
Cellogique Corporation to be Exclusive Distributors of Croma Princess in Saudi Arabia and the United Arab Emirates
June 1, 2013
Cellogique Corporation and Croma Princess are happy to announce the expansion of distribution of Croma Princess fillers and mesotherapy to include Saudi Arabia and the United Arab Emirates.
Croma Princess suggests an alternative to plastic surgery with their innovative and sophisticated fillers and mesotherapy. Croma Princess’ revolutionary hyaluronic dermal filler"...
Cellogique Corporation Partners with Colorescience to Launch a Line of Mineral Makeup
June 1, 2013
Cellogique Corporation and Colorescience are pleased to announce their new partnership for the distribution of a revolutionary line of mineral makeup in the Middle East and Turkey.
Colorescience boasts “makeup that does more,” by combining the art of makeup with the science of skincare. This cutting edge line of makeup is comprised of high quality ingredients"...
|